AJANTPHARM.NS
AJANTPHARM.NS
INE031B01049
AJANTA PHARMA LIMITED
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 54.072.600.000 45.875.100.000
17.9%
Cost of Revenue 12.477.000.000 11.271.500.000
10.7%
Gross Profit 41.595.600.000 34.603.600.000
20.2%
28.329.600.000 23.319.000.000
21.5%
Operating Income 13.266.000.000 11.284.600.000
17.6%
Pretax Income 13.776.500.000 11.891.600.000
15.9%
Net Income Common Stockholders 10.560.000.000 9.203.900.000
14.7%
-- --
--
-- --
--
ende